...Health info at your doorstep

Day: 4 August 2020

US Begins Clinical Trial of Antibody-Drug for COVID-19

US Begins Clinical Trial of Antibody-Drug for COVID-19

Coronavirus, NEWS
The United States has started late-stage clinical trials into a drug formulated to fight COVID-19, officials said Tuesday. The medicine is an antibody against the new coronavirus called LY-CoV555, which was identified in the blood sample of a recovered patient by Canada’s Abcellera Biologics. It was then developed synthetically for mass production by US-based Lilly Research Laboratories in partnership with Abcellera. The Phase 3 trial will initially enrol some 300 volunteers around the world who have been hospitalised with mild to moderate COVID-19 with fewer than 13 days of symptoms. Each will be assigned either the medicine, which will be injected intravenously, or a placebo. Patients will also receive standard care for COVID-19, including the antiviral remdesivir. The
Risks of COVID-19 Infection through Breastfeeding Negligible —WHOv

Risks of COVID-19 Infection through Breastfeeding Negligible —WHOv

NEWS, Women's health
The World Health Organisation says the risk of COVID-19 infection through breastfeeding is negligible and has never been documented. Head of the organisation’s Food and Nutrition Action in Health Systems unit, Dr. Laurence Grummer-Strawn, stated this on Tuesday, according to the United Nations. In a report, the UN quoted Grummer-Strawn as making the statement at a news briefing on the 2020 World Breastfeeding Week where he appealed for greater support for the practice. This year’s event is coming amid warning by the WHO that lack of mother’s milk is linked to 820,000 child deaths a year, costing the global economy 300 billion dollars (N114 trillion). “WHO has been very clear in its recommendations to say absolute breastfeeding should continue. “We have never documented, anyw
FG to Develop Interventions to Reduce COVID-19 Fatalities

FG to Develop Interventions to Reduce COVID-19 Fatalities

Coronavirus, NEWS
Minister of Health, Dr Osagie Ehanire, says efforts are ongoing to develop innovative interventions to reduce COVID-19 case fatalities to below one per cent. Ehanire said this at the Presidential Tasks Force (PTF) on COVID-19 daily briefing on Monday in Abuja. According to him, fatalities at present are at two per cent, especially for the elderly and those with co-morbidities. Ehanire said that PTF members were aligned in non-pharmaceutical key role interventions in controlling new infections, as the measures of wearing of masks and avoiding crowds were easy, cheap and proven to be effective. He added that “we would work with state governments to prepare necessary space and human resources at general hospitals or Primary Healthcare Centres to train and set u
COVID-19 Vaccines now in Phase 3 Clinical Trials– WHO

COVID-19 Vaccines now in Phase 3 Clinical Trials– WHO

Coronavirus, NEWS
The Director-General of the World Health Organization (WHO), Tedros Ghebreyesus, says a number of vaccines are now in phase three clinical trials to prevent COVID-19 pandemic. Mr Ghebreyesus made this known at a virtual news conference on Monday at the WHO Headquarters in Geneva. The director-general said: “We all hope to have a number of effective vaccines that can help prevent people from infection. “However, there’s no silver bullet at the moment and there might never be; for now, stopping outbreaks comes down to the basics of public health and disease control. “Testing, isolating and treating patients, tracing and quarantining their contacts. Do it all. “Inform, empower and listen to communities. Do it all. “For individuals, it’s about keeping physical distance,
COVID-19: NCDC Tracking 11,000 Contacts Nationwide-Ihekweazu

COVID-19: NCDC Tracking 11,000 Contacts Nationwide-Ihekweazu

Coronavirus, NEWS
The Nigeria Centre for Disease Control (NCDC) has said it was tracking 11,000 COVID-19 contacts nationwide. The Director-General of the agency, Dr. Chikwe Ihekweazu, said the agency would continue to pay attention to contact tracing, which he described as a vital aspect of the campaign to curb the pandemic. Speaking during a briefing by the Presidential Task Force on COVID-19 in Abuja yesterday, Ihekweazu also said the NCDC was liaising with the African Centre for Disease Control to obtain the COVID-19 vaccines for the continent whenever it is available. According to him, about 226 vaccines are in different stages of development, adding that clinical trials carried out so far were encouraging. He said, “On contact tracing, right now, we are following about 11,00 contacts na